Primary Care Clinics in Booneville, KY Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Mountain Comprehensive Health Corporation Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 826 Ky 11 N, Booneville, KY 41314 Phone: 606-593-6395 Fax: 606-593-5916 |
Booneville Medical Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Hwy 11 South, Booneville, KY 41314 Phone: 606-693-0531 Fax: 606-693-0535 |
Owsley County High School Based Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 177 Shepherd Rd Ste A, Booneville, KY 41314 Phone: 606-593-6006 |
Family Practice Clinic Of Booneville, Inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Mulberry St, Suite A, Booneville, KY 41314 Phone: 606-593-6023 Fax: 606-593-6087 |
Owsley County Elementary School Based Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 372 Ky 28 Ste A, Booneville, KY 41314 Phone: 606-593-7888 |
Juniper Health Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 10355 Highway 30 W, Booneville, KY 41314 Phone: 606-464-0151 Fax: 606-464-0152 |
News Archive
Enrollment complete in Vertos Medical's U.S. IRB I "mild" procedure Patient Outcomes Trial
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.
InSite Vision commences enrollment in BromSite Phase 3 clinical trial
InSite Vision Incorporated today announced that patient enrollment has begun in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.
Study describes how Dbr1 gene halts toxic buildup of TDP-43-a protein
Scientists at the Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein found in nerve cells. These findings point to a potential new tactic for treating a variety of neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease)-a fatal disease for which there is no cure.
Information overload on COVID-19 leads people to pick out bizarre, unhelpful choices
That the COVID-19 situation has been accompanied by a relentless flood of information is evident from a quick examination of newspaper front pages, top stories on any news channel, or trending topics on Twitter.
Research in people with IBS shows link between gut microbiota and brain regions
A new study by researchers at UCLA has revealed two key findings for people with irritable bowel syndrome about the relationship between the microorganisms that live in the gut and the brain.
› Verified 4 days ago